Androgen Receptor in Breast Cancer—Clinical and Preclinical Research Insights
The Androgen Receptor (AR) is emerging as an important factor in the pathogenesis of breast cancer (BC), which is the most common malignancy among females worldwide. The concordance of more than 70% of AR expression in primary and metastatic breast tumors implies that AR may be a new marker and a po...
Main Authors: | Aristomenis Anestis, Ilianna Zoi, Athanasios G. Papavassiliou, Michalis V. Karamouzis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/2/358 |
Similar Items
-
Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
by: Ramesh Narayanan, et al.
Published: (2016-12-01) -
Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
by: Maša Brumec, et al.
Published: (2021-04-01) -
Editorial: The Androgen Receptor in Breast Cancer
by: Anna Tesei, et al.
Published: (2021-01-01) -
Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease
by: Maria Vittoria Dieci, et al.
Published: (2019-06-01) -
Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
by: Mirco Pistelli, et al.
Published: (2014-06-01)